Ticker Symbol: BLUWU

Blue Water Acquisition Corp. - Unit

Exchange: NASDAQ

Company Profile

Clarus Therapeutics Holdings, Inc. is a pharmaceutical company with expertise in developing androgen and metabolic therapies for men and women – including potential therapies for orphan indications. Clarus Therapeutics’ first commercial product is JATENZO®.

Sector: N/A

Industry: N/A

Standard Industrial Classification Code (SIC code): N/A

Address: N/A

Website: clarustherapeutics.com

CEO: N/A

Tags: N/A

Pricing

Last Updated: December 31, 1969 07:00 PM EST

Previous Close: -

Change: - ( 0.00%)

Days Range: $9.03 - $10.57

Beta: -

52wk. High: -

52wk. Low: -

Ytd. Change 0.00%

50 Day Moving Average: -

200 Day Moving Average: -

Shares Outstanding: 5000000

Valuation

Market Cap: 5.2B

PE Ratio: -

EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -

Dividend Yield (TTM): 0.00%

Ex-Dividend Date: N/A